1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S. C. W.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Preoperative needle biopsy and tumor spread through alveolar spaces (STAS) in resected lung adenocarcinomas
    Meeting Abstract

    Kameda, K.; Eguchi, T.; Lu, S.; Solomon, S.; Bott, M.; Jones, D.; Rekhtman, N.; Travis, W.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets
    Meeting Abstract

    Hristov, B.; Eguchi, T.; Chintala, N.; Lu, S.; Bott, M.; Travis, W.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Minimally invasive lobectomy is associated with lower noncancer mortality in elderly: A propensity-score matched analysis
    Meeting Abstract

    Hristov, B.; Eguchi, T.; Isbell, J.; Park, B.; Tan, K. S.; Rusch, V.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A stem-cell oriented phylogeny of non-small cell lung cancers
    Meeting Abstract

    Downey, R.; Riester, M.; Wu, H. J.; Moreira, A.; Michor, F.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations after failure of prior therapy
    Meeting Abstract

    Paik, P.; Stammberger, U.; Bruns, R.; Overton, L.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
    Meeting Abstract

    Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • The use of immunohistochemistry improves the diagnosis of SCLC. An international reproducibility study in a demanding set of cases
    Meeting Abstract

    Thunnissen, E.; Borczuk, A.; Flieder, D.; Witte, B.; Beasley, M. B.; Chung, J. H.; Dacic, S.; Lantuejoul, S.; Russell, P.; Den Bakker, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A multi-national cohort validation of procedure-specific nomograms to predict recurrence for small lung adenocarcinomas
    Meeting Abstract

    Bains, S.; Eguchi, T.; Warth, A.; Yeh, Y. C.; Nitadori, J. I.; Woo, K.; Chou, T. Y.; Dienemann, H.; Muley, T.; Nakajima, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Safety, clinical activity and biomarker results from a phase lb study of erlotinib plus atezolizumab in advanced NSCLC
    Meeting Abstract

    Rudin, C.; Cervantes, A.; Dowlati, A.; Besse, B.; Ma, B.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V.; Sarkar, I.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save